| 3601 |
Bone Marrow |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
44 |
| 3602 |
Bone Marrow |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
64 |
| 3603 |
Bone Marrow |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
47 |
| 3604 |
Bone Marrow |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
53 |
| 3605 |
Bone Marrow |
Allogeneic
|
Combined Immunodeficiency
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
1 |
| 3606 |
Bone Marrow |
Allogeneic
|
Combined Immunodeficiency Syndrome With Hyper-Igm
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
5 |
| 3607 |
Bone Marrow |
Allogeneic
|
Fanconi Anemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
4 |
| 3608 |
Bone Marrow |
Allogeneic
|
Hemophagocytic Lymphohistiocytosis (Hlh)
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
3 |
| 3609 |
Bone Marrow |
Allogeneic
|
Hurler Syndrome
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
3 |
| 3610 |
Bone Marrow |
Allogeneic
|
Immunodeficiency
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
2 |
| 3611 |
Bone Marrow |
Allogeneic
|
Inherited Immune System Disorder
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
1 |
| 3612 |
Bone Marrow |
Allogeneic
|
Ipex- Other Immune
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
20 |
| 3613 |
Bone Marrow |
Allogeneic
|
Leukemia Lymphoblastic Acuta
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
6 |
| 3614 |
Bone Marrow |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
70 |
| 3615 |
Bone Marrow |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
10 |
| 3616 |
Bone Marrow |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
2 |
| 3617 |
Bone Marrow |
Allogeneic
|
No Data
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
30 |
| 3618 |
Bone Marrow |
Allogeneic
|
No Data
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
67 |
| 3619 |
Bone Marrow |
Allogeneic
|
No Data
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
59 |
| 3620 |
Bone Marrow |
Allogeneic
|
No Data
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
59 |
| 3621 |
Bone Marrow |
Allogeneic
|
No Data
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
69 |
| 3622 |
Bone Marrow |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
55 |
| 3623 |
Bone Marrow |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
14 |
| 3624 |
Bone Marrow |
Allogeneic
|
Non-Hodgkin Lymphoma
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
41 |
| 3625 |
Bone Marrow |
Allogeneic
|
Osteopetrosis
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
7 |
| 3626 |
Bone Marrow |
Allogeneic
|
Other Leukemia Specify
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
35 |
| 3627 |
Bone Marrow |
Allogeneic
|
Other Myelofibrosis
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
72 |
| 3628 |
Bone Marrow |
Allogeneic
|
Refractory Cytopenia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
7 |
| 3629 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
23 |
| 3630 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
53 |
| 3631 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
12 |
| 3632 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
5 |
| 3633 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
13 |
| 3634 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
12 |
| 3635 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
32 |
| 3636 |
Bone Marrow |
Allogeneic
|
Severe Combined Immunodeficiency
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
1 |
| 3637 |
Bone Marrow |
Allogeneic
|
Severe Combined Immunodeficiency
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
1 |
| 3638 |
Bone Marrow |
Allogeneic
|
Wiskott-Aldrich Syndrome
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
9 |
| 3639 |
Apheresis |
Allogeneic
|
Acute Biphenotypic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
28 |
| 3640 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
17 |
| 3641 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
73 |
| 3642 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
38 |
| 3643 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
31 |
| 3644 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
24 |
| 3645 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
27 |
| 3646 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
54 |
| 3647 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
51 |
| 3648 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
65 |
| 3649 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
47 |
| 3650 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
10 |
| 3651 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
23 |
| 3652 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
5 |
| 3653 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
28 |
| 3654 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
58 |
| 3655 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
13 |
| 3656 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
55 |
| 3657 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
42 |
| 3658 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
20 |
| 3659 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
58 |
| 3660 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
52 |
| 3661 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
68 |
| 3662 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
32 |
| 3663 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
19 |
| 3664 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
61 |
| 3665 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
42 |
| 3666 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
3 |
| 3667 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
29 |
| 3668 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
8 |
| 3669 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
54 |
| 3670 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
20 |
| 3671 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
6 |
| 3672 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
61 |
| 3673 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
24 |
| 3674 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
66 |
| 3675 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
38 |
| 3676 |
Apheresis |
Allogeneic
|
Acute Lymphoblastic Leukemia – Relapse
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
38 |
| 3677 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
40 |
| 3678 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
58 |
| 3679 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
23 |
| 3680 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
59 |
| 3681 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
62 |
| 3682 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
73 |
| 3683 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
41 |
| 3684 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
48 |
| 3685 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
64 |
| 3686 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
24 |
| 3687 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
50 |
| 3688 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
55 |
| 3689 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
66 |
| 3690 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
46 |
| 3691 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
69 |
| 3692 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
47 |
| 3693 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
45 |
| 3694 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
70 |
| 3695 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
68 |
| 3696 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
70 |
| 3697 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
63 |
| 3698 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
37 |
| 3699 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
21 |
| 3700 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2021
|
Standard Therapy
|
Poland
|
60 |